Journal History

2010 The inaugural issue was released. JFB was published as a quarterly journal.
2014 JFB was indexed in PubMed - National Library of Medicine (NLM).
JFB published its 100th paper.
2017 JFB announced the first edition of the Travel Award.
2018 JFB was indexed in Emerging Sources Citation Index - Web of Science (Clarivate Analytics), Scopus, Biological Abstracts, and BIOSIS Previews.
2019 JFB received its first CiteScore (2019) of (4.1).
2020 JFB received a new CiteScore (2020) of (7.3).
2021 JFB was indexed in Science Citation Index Expanded (SCIE) - Web of Science (Clarivate Analytics).
JFB published its 500th paper.
JFB announced the first Highly Cited Paper Award.

JFB established the following sections:

Bone Biomaterials;
Dental Biomaterials;
Antibacterial Biomaterials;
Biomaterials for Tissue Engineering and Regenerative Medicine;
Biomaterials for Drug Delivery;
Biomaterials for Cancer Therapies;
Cell-Biomaterial Interaction;
Biomaterials and Devices for Healthcare Applications;
Synthesis of Biomaterials via Advanced Technologies.

2022 JFB received a new CiteScore (2021) of 10.0, ranked Q1 in "Biomedical Engineering".
JFB received its first Impact Factor (4.901), ranked Q2 in "Engineering, Biomedical" and "Materials Science, Biomaterials".
2023 JFB adopted a monthly publication schedule.

Editor-in-Chief

2010–2023 Editor-in-Chief: Prof. Dr. Francesco Puoci
2023–present Editor-in-Chief: Prof. Dr. Pankaj Vadgama

Section Editor-in-Chief

2021–2023 Section Editor-in-Chief: Dr. John G. Hardy for the section on Biomaterials and Devices for Healthcare Applications
2021–present Section Editor-in-Chief: Prof. Dr. Gianrico Spagnuolo for the section on Dental Biomaterials
Section Editor-in-Chief: Prof. Dr. John H.T. Luong for the section on Antibacterial Biomaterials
Section Editor-in-Chief: Prof. Dr. Daniel X.B. Chen for the section on Biomaterials for Tissue Engineering and Regenerative Medicine
Section Editor-in-Chief: Dr. Serena Danti for the section on Biomaterials for Cancer Therapies
2022–present Section Editor-in-Chief: Prof. Dr. Li Ren for the section on Synthesis of Biomaterials via Advanced Technologies
Back to TopTop